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Counting Us In: Problems and Opportunities in
Health Research on Transgender and GenderNonconforming Communities
Christoph Hanssmann1
INTRODUCTION
In the last decade, the emergence into the public consciousness of
transgender as an identity and as a field of study has had a profound impact
on individuals who claim, or are incorporated in some way, by the term
“transgender.” This shift has resulted in an increase in the degree to which
public health research incorporates questions about transgender health. The
past several years have seen a rise in the number of epidemiological studies
and reviews concerning transgender individuals.2 These findings are being
taken up in the work of activists and policymakers. While this may be
considered a success in terms of gaining empirical evidence to ground
claims for increased access to health and social services and to support
initiatives that reduce health disparities among transgender and gendernonconforming individuals, it may also carry a number of problematic
implications.
This article examines the context of the emergence of increased demands
for trans health research and practice and argues that simple inclusion in
most existing frameworks of health research and biomedicine will not yield
a broadly effective result. Health research in other marginalized healthbased projects, such as HIV/AIDS research in gay men’s health, has taken
some missteps that we may take care to avoid in navigating a path that is
more constructive and efficacious for the health and wellbeing of trans
gender-nonconforming populations. Doing so necessitates a critique of the
following: the professionalization of trans health advocacy in the context of
social movements’ incorporation by nonprofits; a critique of state-based
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violence and its effect on health outcomes, as well as the relationship of
health research to state projects to increase criminalization and surveillance;
and a critical examination of the role of health research and advocacy in
reifying narrow identity categories that erase the complex experiences and
multiple vectors of oppression faced by trans populations.
This article will explore several questions in an effort to shed light on
areas of tension and ambivalence with regard to transgender inclusion in
health research:
1. In what ways do the foci of epidemiological studies (frequently, the
risk of violence or HIV infection) frame the ways these studies are
discussed and used as a basis for action?
2. What is the significance of including transgender individuals in
health research, and what is at stake in doing so?
3. How does the category of “transgender,” as it is mobilized in
epidemiological research, obscure and complicate issues relating to
other factors of marginalization and social determinants of health?
4. How do epidemiological data and inclusion, or exclusion from health
research in general, “loop back”3 to affect transgender people’s
concepts of themselves as individuals and as members of trans
communities?
While there is much articulated resistance in transgender and gendernonconforming communities to the pathologizing research that dominated
in the past,4 there is palpable enthusiasm for more current models of health
research in general and epidemiological and pharmacological health
research in particular. The reasons for this support are many and are
generally quite valid. For example, some transgender and gendernonconforming people pursue specific medical interventions that have not
been well evaluated with regard to efficacy and potential risks.5
Additionally, groups involved in trans activism and advocacy, as well those
involved in research, have grown in number and scope. Now that we may,
in some instances, influence research agendas, can we not drive their
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direction in ways that will be supportive of our communities and of our
health and wellbeing?
I begin this article with an assumption that trans health is important and
valid, that all transgender and gender-nonconforming people are entitled to
exceptional healthcare that offers access to good health to whatever extent
possible inclusive of gender-confirming and supportive care, and that none
of us should encounter barriers to primary or specialty medical care that we
require. Additionally, I assume that health research, in general, is an
important pursuit that transgender and gender-nonconforming people can
benefit from. However, I also intend to issue certain cautions about how this
research is pursued and positioned, and I warn that this work must be
organized in such a way as to attend to the lopsided distribution of benefits
and uneven vulnerability on the part of certain populations of trans people,
such as trans people of color and poor trans people, rather than focus only
on certain sectors of these communities with greater relative privilege.

I. SHIFTS IN APPROACH: HEALTH RESEARCH ON TRANS AND LGBTQ
COMMUNITIES
In the past several years, there has been a marked increase in the number
of epidemiologic and other health research studies that concern transgender
individuals.6 Many of these studies differ significantly in content and
approach from medical studies of transsexuals7 conducted in the early- to
mid-twentieth century.8 In general, the literature on transgender health that
is currently available focuses on health disparities, disease prevalence and
incidence, and particular associations of trans identity with negative health
outcomes (such as experience of violence). This contrasts with earlier
studies that explored the etiology of transsexuality itself, and its relationship
to, or overlap with, homosexuality.9 In other words, these studies have
shifted from focusing on a disease to focusing on a community.
As far as we know, these earlier studies were conducted strictly by nontrans psychiatrists, sexologists, and physicians. In contrast, one feature of
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this new wave of trans health research is that in some cases, transgender or
gender-nonconforming individuals are directly involved in the design,
implementation, and dissemination of these studies.10 Many serve as
principal investigators, researchers, and medical doctors. To a growing
degree, trans individuals are seen as experts within our own communities.11
A. Trans Health in the Context of LGBTQ Health Advocacy
LGBTQ health has recently taken shape as a unique form of health
activism within the United States. Trans health advocacy has emerged as a
distinctly marginal aspect of this project. While at times it has claimed
distinct needs,12 trans health advocacy is frequently subsumed within
“LGBTQ health.”13 As Steven Epstein has noted, LGBTQ health advocacy
initially took shape within grassroots activism. Its origins were in the
feminist women’s health movement and in the approaches that the group
ACT UP (a radical grassroots group formed in response to the AIDS crisis)
initially took in targeting federal biomedical institutions.14 Early LGBTQ
health activism targeted pervasive homophobia in clinical settings and the
lack of attention political leaders gave to the effect of AIDS on LGBTQ
communities. Gradually, as activists gained greater membership as what
Epstein calls “lay experts” and “treatment activists,” (or activists who
gained knowledge about biomedical research for the purpose of influencing
the decisions of researchers and other powerful stakeholders) and as
increased resources were earmarked for pharmacological and health
research on HIV/AIDS, objectives shifted.15
Epstein discusses some of the tactics of grassroots community-based
health activism of the early 1990s, including the formation of locally-based
organizations dedicated to service provision, education, and prevention and
engagement in militant direction action projects, street activism and selfeducation. He traces several departures from these tactics toward a statebased focus on improving the health status of LGBTQ communities.16 Calls
to national membership organizations—like the Gay and Lesbian Task
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Force—to adopt an LGBTQ health agenda as well as greater involvement of
lesbians in cancer prevention and research—breast cancer, in particular, as
an area of interest—with special focus on groups like the National Cancer
Institute, are both examples of state-based health activism.17 In addition, he
notes, LGBTQ physicians began to rally for shifts from within the medical
establishment. First formed as the American Association for Physicians for
Human Rights, this group was later renamed the Gay and Lesbian Medical
Association (GLMA).18 In 1996, GLMA added bisexual and transgender
health to its list of concerns.19
In this shift to state-based health activism, the focus on LGBTQ health
moved from community-based concerns about homophobia in clinical
settings to broader health disparities,20 with particular attention to the
increased burden of disease and disease risk (AIDS/HIV, cancer, tobacco
use, cardiovascular disease, and a variety of others) in these communities
when compared to other social groups.21 Concurring with this change in
focus was a change in agenda: broad epidemiologic research became a
primary objective of LGBTQ health activism.22 This was seen as important
both in empirically establishing widespread health disparities and in the
resulting evidence being available for use in leveraging resources to
cultivate health and prevent disease in these communities.23
With this shift in LGBTQ health has come some degree of incorporation
and institutionalization within national health research agendas. For
example, GLMA published a compendium to the report, Healthy People
2010, which focused on LGBTQ health disparities and areas for continued
research.24 In 1998 and 1999, the American Public Health association
passed two resolutions calling for increased inclusion of LGBTQ people (in
1998) and transgender individuals in particular (in 1999) in health
research.25
While transgender communities are included in this work, our needs and
concerns are frequently sidelined, particularly as it becomes more broadly
institutionalized. Federal officials, it is assumed, find categories such as
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transgender “too ‘out there,’”26 and resist making changes to entrenched
methods of data gathering, such as including demographic options that are
not restricted to male or female.27 This parallels some of the ways that trans
communities have been left out of a variety of state-based initiatives. For
example, the Employment Non-Discrimination Act (ENDA) is a federal
legislative bill that seeks to protect employees from being fired on the basis
of sexual orientation or gender identity (the latter of which was only added
to the bill’s language in 2007, after its initial introduction in 1994).28 In
2007, the year the bill was passed by the House, “gender identity” was
eliminated for fear that it would not pass if it protected more than just
sexual orientation.29
Trans and LGBTQ movements are often closely tied, “in part because
United States culture often conflates sexual orientation and gender
expression, and in part because of a long history of sexual and gender
outsiders finding community together, resisting oppression together, and
often understanding their identities through and against each other.”30
There is some ambivalence about the relationship between emerging
trans struggles and LGBTQ activism, particularly mainstream advocacy
projects that are characterized by the pursuit of state inclusion such as gay
marriage and participation in the military. Trans and gender-nonconforming
people face concerns that differ somewhat from the concerns faced by
gender-conforming LGBTQ people. These unique concerns, combined with
the hesitancy of state-based projects to include transgender and gendernonconforming people, have caused trans activists and advocates to pursue
trans-specific research and initiatives.
B. Trans Health Advocacy as a Unique Pursuit
As trans health advocacy emerges as a pursuit separate and unique from
LGBTQ health advocacy, individuals in trans communities are increasingly
calling for more health research, regardless of the barriers to inclusion
within broad-based federal research programs. For some, this is noteworthy

TRANSGENDER ISSUES AND THE LAW

Counting Us In

because it indicates a shift away from distrust of the biomedical
establishment, which continues to play a particularly insidious role in the
lives of many trans individuals, exercising coercive and rigorous gatekeeping practices in managing patients’ gender transitions, and acting as an
authority in establishing trans identities as strictly medicalized. Much trans
activism is based in a critique of medicalization because:
1. Physicians are seen as the ultimate authority on a person’s
gender identity, above and beyond a person’s self-identification
2. The pathologization of the category of trans stabilizes non-trans
identity as non-pathological
3. Other vectors of oppression, such as class, race, age and ability
figure into basic health care access, the lack of which may have
negative implications in healthcare providers making diagnoses
concerning trans identity
4. The law has incorporated a medicalized model of trans identity
that affects trans people’s ability to obtain essential legal
documents, such as identification, unless they have “proof” of
medically-validated trans identity.
However, it is possible that the earlier described shift of transgender and
gender-nonconforming people taking a greater role in medicine and
health research has made biomedicine more responsive, in limited
instances, to the needs of these communities.
1. Specific Issues Related to Trans Health Research
Similar to LGBTQ health activism, calls for trans health research focus
on exploring the existence and pervasiveness of health disparities among
transgender and gender-nonconforming communities.31 This is necessary to
gain a better understanding of how to mitigate the effects of these inequities
and to build broader and more effective interventions to meet these goals.
However, there are several reasons that trans health distinguishes itself
from LGBQ health advocacy and investigates disparities through the lens of
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trans identity specifically. Epidemiologic research may focus on some
similar health outcomes and disproportionate disease burden,32 but
researchers assume that risk factors differ in various ways. In addition,
some transgender and gender-nonconforming health advocates are
interested in health research that departs from concerns of genderconforming LGBQ populations. For example, some transgender and
gender-nonconforming individuals may pursue gender-confirming medical
interventions, such as hormone treatment or surgeries, and these require
both specific research and clinical competencies.33 Last, the medical
profession views transgender as a “condition” or a clinical diagnosis in
ways that are not the case with regard to sexual orientation.34 This
contextualizes and positions trans health activism and research in ways that
differ from how LGBQ health activism has positioned itself.
For example, in contrast to non-trans-LGBQ communities, there is great
interest in pharmacological research on the long-term effects of
masculinizing or feminizing hormones,35 although I will not explore this
topic in-depth in the context of this article. This topic merits its own
exploration of the economies of pharmaceutical research and marginalized
populations in the context of biomedicine. There is also a great deal of
interest in incidence and prevalence of HIV/AIDS in transgender and
gender-nonconforming populations, particularly given the recent high rates
that have been documented among trans women in metropolitan areas.36
These and other issues illustrate the ways in which trans health advocacy is
concerned with the potential differences in risk factors and health outcomes
that set it apart from LGBQ health advocacy in general.
2. Trans health Research: How LGBTQ Health Advocacy Shaped
Priorities
a) Topical and Methodological Foci
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Despite some of the ways trans health activism and research has become
distinct from LGBTQ health advocacy, it carries vestiges of its growth from
within this context. Trans health research agendas have been articulated
from a variety of contexts, ranging from state-based37 to communityengaged.38 It is important to consider how these distinct agendas emerged
and what the consequences are of following the state-based research
trajectories of LGBTQ health advocacy, both of which I will attend to in the
next section. In the context of this article, “state-based” strategies are those
that aim to improve population health outcomes spanning broad and
geographically dispersed groups of people. Strategies may be in the form of
federal programs, legislation, state mandates, large-set data collection and
quantitative analysis, and so on. “Community-based” strategies, in contrast,
are generally local to smaller geographic areas and population subsets.
These may be smaller-scale policy-based projects, targeted interventions, or
research focusing on more in-depth data collection and/or smaller or more
specific datasets.
It is likely that some of the focus on HIV/AIDS as a trans health issue
emerged in part because of trans health originating in part from LGBTQ
health advocacy more broadly. From within state funded and administered
research programs in the area of HIV/AIDS, the issue of disproportionate
disease burden for trans people emerged.39 However, the Centers for
Disease Control (CDC), the primary federal body in charge of disease
surveillance in the United States, failed in their epidemiologic data
gathering to distinguish between “men who have sex with men” (MSM) and
trans women who have sex with men, lumping both groups into the MSM
category.40 Thus, HIV/AIDS as a trans health concern was subsumed within
gay and bisexual men’s health. Notably, trans men who have sex with other
men (trans or non-trans) did not specifically figure into data collection as
MSM.
Noting this error in conceptual conflation on the part of the CDC, some
researchers and trans health activists set out to establish disparities in health
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outcomes with regard to HIV/AIDS incidence and prevalence rates as
distinct from patterns in gay and bisexual non-trans men (or MSM more
broadly).41 Disease incidence and prevalence patterns are also linked to
funding allotment for prevention efforts, and given researchers’ assertions
that funding streams directed towards prevention efforts for MSM do not
address the needs of transgender individuals,42 activists and researchers
prioritized establishing a body of data to demonstrate HIV/AIDS as a
specific issue within trans communities.
This paved the way for a variety of small-scale epidemiologic studies to
track HIV incidence and prevalence rates in trans communities. These
concerned trans women, though more recent studies have also investigated
HIV/AIDS incidence and prevalence, as well as risk factors, among trans
masculine individuals.43
Some of these studies were conducted in collaboration with transgender
and gender-nonconforming communities.44 Community-based participatory
health methods, which I will discuss in more detail later in the article, also
use epidemiologic approaches to gathering information about disease
burden in communities. However, they do so in a way that puts stake in
local and community knowledge about context and underlying causes.
These projects engage academically unaffiliated community members in the
process of developing and advancing topics to pursue in health research.45
In general, community-based studies have tended to undertake multilayered investigations of HIV/AIDS incidence and prevalence as one of
many factors affecting trans health and its occurrence in the context of other
factors affecting health (e.g., lack of access to employment or housing
leading to survival sex work).
This approach contrasts with traditional research methods that assume
scientific experts are best positioned to discern the reasons for disease and
to design interventions for prevention. While most HIV/AIDS and health
research has taken a traditional approach, notable exceptions have produced
nuanced understandings of health inequities in trans and gender-
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nonconforming communities and rich descriptions of the context in which
these occur. They also focus on some of the important differences among
individuals within trans communities and how these make a difference in
health outcome.
In some ways, research on HIV/AIDS in trans communities has seen an
overlapping of state-based agendas with community-based research.
Researchers with the former orientation have used traditional epidemiologic
data gathering that has emerged from national surveillance programs to a
similar end—to secure funding and design interventions. Researchers with
the latter orientation have employed different methods but with a similar
topical focus on HIV/AIDS, which initially emerged and gained momentum
from state-based research agendas. This tension highlights some of the
broader questions about trans health in relation to LGBTQ health: how does
trans health go about articulating a different approach to health research and
also begin to develop its own complex topical foci when its history is so
intertwined with that of LGBTQ health? What might we learn from the
direction of LGBTQ health advocacy?
b) Funding Structure, Professionalization, and the Turn Away from
Community-Based Work
The relationship between movements and funding is important when
considering the factors that frame health research and the disparities to
leverage funding. Nonprofit agencies and nongovernmental agencies have,
in the past several decades, grown to supplant the previous role of statebased public benefits programs that grew from the New Deal.46 Named the
“shadow state” by Jennifer Wolch,47 this move has created the context for a
shift in the realm of activism into what many critics have called the
“nonprofit industrial complex.”48 This has been the source of many fissures
within activist communities and has been criticized in particular for its
move towards professionalization and its turn away from grassroots models
of activism.49 One problematic feature of this transition in activism is the
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degree to which the viability of projects is linked to palatability. This link is
evaluated by private and governmental funders, rather than the urgency or
priority determined by affected members of the communities the projects
are designed to serve.50
Similar to Epstein’s articulation of the shift from a community-based
LGBTQ health movement to one focused on state-based research agendas,
mainstream gay and lesbian politics in the past two decades have become
increasingly focused on state legislative goals over grassroots communitybased organizing.51 This move has created a situation, as Manazala and
Spade outline, of social movements becoming more reliant on corporations
and on foundations with accumulated wealth, and, through a process of cooptation, gay and lesbian rights work has tended increasingly towards work
protecting individual rights of property over collective wellbeing.52
These trends of professionalization and cooptation have impacted health
advocacy, causing HIV/AIDS to come to define gay health in the 1980s and
1990s, much to the detriment of gay health advocates in establishing a
broad and far-reaching health program.53
As trans and gender-nonconforming health activists set priorities for trans
health, it is important to consider some of the ways that issues at a federal
level may not align directly with the priorities of local trans and gendernonconforming communities, particularly since these communities differ
radically along lines of race, ethnicity, class, nation of origin, immigrant
status, age, sexual orientation, ability, religion, geographic location, and so
on. Instead, an expanded focus on community-based health research
projects may have a greater potential to attend to the particular local needs
of trans and gender-nonconforming communities, given the disparate and
differing needs within these populations. Without the capacity for
complexity, flexibility and geographic specificity allowed by more deeply
focused and localized research, it is likely that research projects will fix
upon a less nuanced set of analyses within this population, possibly
consolidating relative benefit among those with the most relative privilege.
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II. ACHIEVEMENTS AND CONCESSIONS OF TRANS INCLUSION IN
HEALTH RESEARCH
There have been a variety of achievements in recent years related to trans
inclusion in health activism and research. These include recent (though not
broadly incorporated) recognition of the need for health insurance coverage
for trans-specific healthcare treatments and the expansion of trans health as
an area for investigation within community-based research. However, with
achievements often come concessions, and I will point out areas where trans
inclusion in health research could benefit from a thorough examination of
its goals and a reassessment of some of its current trajectories.
In 2008, the American Medical Association passed Resolution 122
entitled “Removing Barriers to Care for Transgender Patients.” It reads,
“Resolved, that our American Medical Association support public and
private health insurance coverage for treatment of gender identity disorder
as recommended by the patient’s physician.”54 While the resolution
maintains the restrictive and coercive structure that trans and gendernonconforming people in the United States must navigate,55 it is a
significant victory in the effort to reduce barriers to trans healthcare. As
gender-confirming medical interventions for trans people have remained
largely uncovered by public benefits programs and private insurance
companies, those individuals who seek hormone and surgical treatments
have, barring significant access to wealth, found many of these to be out of
reach.56 The AMA resolution does nothing to disentangle the complex and
contradictory network that trans and gender-nonconforming people are
subject to with regard to legal identification, gender segregated facilities,
and other sources of anxiety, frustration, and lack of safety.57 However, if
taken up in medical practice, it may do a great deal to remove an important
barrier to healthcare for many trans and gender-nonconforming individuals.
The ultimate effectiveness of the resolution remains to be seen, but it may
be indicative of the direction in which medical practice is moving.
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More recent needs-assessment studies have helped increase the body of
knowledge about trans and gender-nonconforming health concerns and
needs. These studies are in addition to research studies that focus solely on
HIV/AIDS incidence and prevalence and are an achievement in establishing
some of the widespread barriers to health that trans and gendernonconforming people regularly encounter.58 These have served both to
highlight pressing problems and needs within trans and gendernonconforming communities, as well as capture data about health status and
areas for further research within these populations. Most of these studies
document issues related to employment and housing access, barriers to
high-quality primary and medical care, and exposure to transphobic
violence. These findings can help ground claims for improved access to
health and social services, and document the pervasiveness of barriers to
health and wellbeing for many individuals. It is likely that these studies
have played a role in establishing the body of knowledge that set into
motion broad policy decisions such as the AMA resolution described above.
In addition, such evidence is currently used to justify the development of
trans-specific agencies, services, and other community-based projects.59
Despite these important gains, there remain issues which have not been
attended to thoroughly in conceiving a model for trans health with the
potential to transform and support the health and wellbeing of trans and
gender-nonconforming communities. First, we must exercise caution in how
we use the term “transgender” as a category, and how it might collapse
important differences within it. We also must remain cognizant of who
might be left out in the choice to use this particular term. For example,
“transgender” is a category that has varying degrees of resonance among
those incorporated within the term, and identification with the term may
vary along racial and class lines.60 In addition, people without access to
race, class, and education privilege are likely to encounter more severe and
frequent barriers to health than those with greater access. These differences
may be obscured or attenuated in the context of health research that
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considers transgender people overall. Gender-nonconforming individuals
who are not necessarily included as “transgender” (either based on selfidentification or research criteria), but who face similar or related obstacles
to positive health outcomes, may be excluded from consideration.
Second, we must consider whether the questions we ask and the answers
we seek are necessarily shaped by the context in which we ask them. The
ways in which epidemiologic, health, and pharmacologic research moves
from a certain set of assumptions about what questions matter—and indeed,
what knowledge is valuable or useful—works to prioritize certain answers
and ways of knowing. As Nancy Krieger asserts, epidemiology is, like any
science, at once objective (using defined, rigorous, and replicable methods
to assess refutable propositions) and partisan (reflecting underlying values
and assumptions guiding conceptualization, choice, and analysis of research
problems).61
Marj Plumb notes that “what is knowable about a population and its
health conditions cannot be found solely through quantitative science,” and
that local knowledges are frequently viewed “by scientists as unreliable,
biased, and politically motivated.”62 The investment in professionalization,
expertise, and empirical data at the expense of community-based, local, and
anecdotal knowledges serves to shift credibility away from local
knowledge. Although, at this point, some professionals and experts are
indeed members of trans and gender-nonconforming communities, this
change has not collapsed divisions in access to various types of privilege
that separate “experts” from “laypeople.”
Health research in trans and gender-nonconforming populations takes
place within this set of tensions. As “transgender” is a provisional,
contextual, and mutable term to describe identity and experience, it is
challenging to gather meaningful data using it as a stable analytic category.
Given the legacy of biomedicine with regard to its frequent
conceptualizations of gender-nonconformity as pathological, it is crucial to
consider Krieger’s assertions about the partisan aspects of epidemiology.
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There is surely valuable information to be gained in and through health
research in trans and gender-nonconforming populations, However, there
are a set of underlying values and assumptions that guide choices about how
research questions are framed, how inclusion and exclusion criteria are
formulated, what variables should be considered, and what methodologies
are utilized, and these questions frequently fade into the background. It is
important that we grapple with these and other important questions as health
research in trans and gender-nonconforming populations gains momentum.
In addition, it is vital to remember that rich and valuable information
(including information about health and wellbeing) is knowable through a
variety of means separate from health research.

III. CURRENT TOPICS OF CONSIDERATION IN TRANS HEALTH
RESEARCH
How we frame research questions matters, and so does the context from
which we develop and pursue research agendas. If trans health activists are
to follow LGBTQ health advocacy from community-based, local health
activism to state-based research agendas, we are likely to miss asking
questions that might yield answers that are critical of the state. In addition,
it is useful to consider the ways in which research findings have been used
so far and to speculate about how these may be applied in the future—either
to the benefit or detriment of trans and gender-nonconforming people. Last,
if we are to ask questions about the health and wellbeing of trans and
gender-nonconforming people, we must attend to broader issues as well as
narrow ones: for example, the way that the current structure of the U.S.
healthcare system creates substantial barriers to trans and gendernonconforming people accessing high-quality primary and specialty care.
Epidemiologic surveillance employs technology to monitor diseases and
people at the population level, and uses differences between people to
assess “risk,” or a person’s probability (based on group membership,
environment, or other measured factors) to encounter or develop ill health.63
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Trans health research, particularly epidemiologic research, has centered on
topics that concern data that are broadly incorporated in programs of
surveillance at the level of cities, counties, states, and nations. These topics
generally fit within structures of state priorities in population
management.64 HIV/AIDS incidence and prevalence data and rates of
interpersonal violence, for example, provide the basis for state
policymaking about issues ranging from funding allocation to blood
donation policies65 to patterns of policing and criminal surveillance.
Therefore, data collection, in establishing a concept of risk based on
membership in a particular population, is used to support policies that have
drastic effects on the lives of individuals based solely on their alignment
with a certain group. However, health research in trans communities has
conspicuously not paid attention to the state-based causes of disparities in
health.66 While interpersonal violence is a common topic of study within
LGBTQ and transgender communities, gender-based violence that occurs in
state-based institutions like jails and prisons, group homes, the military,
immigration detention centers, and public benefits offices is rarely
considered as a factor that is broadly detrimental to the health of trans and
gender-nonconforming individuals.67
For example, transgender women of color are frequently profiled and
targeted for being involved in sex work, and experience routine harassment
and arrest as a result. Further, gender-segregated detention facilities usually
result in trans women being placed in men’s facilities, where they are in
danger of violence and harassment by guards, staff, and other inmates.68
This inconsistency in considering interpersonal violence outside the
context of institutional violence is also reflected in the ways policymakers
and legislators draw on established data on violence. One particularly
disturbing example is the way in which rates of interpersonal violence have
been utilized by state apparatuses to advance hate crimes legislation.69
Critiques of this legislation have centered on the ineffectiveness of these
strategies in deterring violence. In addition, hate crimes legislation fails to
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truly correct the problem, due to the expansion of the criminal justice
system, which criminalizes trans people, particularly those that are already
marginalized within trans communities, such as trans women of color.70
Within the context of increased surveillance and criminalization, trans
communities become even more vulnerable to police violence and
surveillance. This demonstrates a tendency to address health problems with
state-based solutions—to understand violence as a crime that ought to be
punished through incarceration rather than to understand violence as a
problem related to social inequities that might be dealt with at a community
level. At a policy level, it demonstrates the ways in which outcome-focused
health research that fails to attend to social context and broad inequities can
result in laws and policies that make the same omission. And again, it fails
to attend to the relationships and parallels between interpersonal and
institutional violence.
This pattern of addressing the material results of inequities rather than the
source of the problem occurs elsewhere in state-based responses to health
crises. For example, state-based responses to HIV/AIDS acknowledge it as
a disease with a disproportionate impact on certain marginalized
communities. However, the focus on disease treatment and management,
rather than on the causes and context of disproportionate impact, such as
poverty, unemployment and other forms of inequity in a context of racism,
classism, sexism, and ableism. Prevention efforts frequently focus on
behavior, rather than the contexts which give rise to the constraint of
options for marginalized populations.
While research has certainly advanced a set of priorities in increasing
access to primary and specialty healthcare and focused health interventions,
it has failed to attend to some important issues. One issue is the way in
which non-coverage of gender-confirming medical interventions for trans
people is largely tied to the structure of the U.S. health system, comprised
primarily of private, employer-based health coverage. Expanding coverage
of these interventions for trans people is crucial within this system, but this
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would not make a difference for trans people who are uninsured or
underinsured. Without broad access to preventive, primary and specialty
services, existing health care disparities, including those within trans and
gender nonconforming populations along lines of race, class, geographic
location and ability, will simply be exacerbated. Access to care for trans and
gender-nonconforming people cannot be separated from the pressing need
to increase access to healthcare in general.
However, these are often viewed as unrelated issues. The very AMA that
issued Resolution 122 has long been an opponent of restructuring the U.S.
health system and universalizing healthcare. In comments submitted to the
Senate Finance Committee, the AMA stated its position against establishing
a public option: “The introduction of a new public plan threatens to restrict
patient choice by driving out private insurers, which currently provide
coverage for nearly 70 percent of Americans.”71 This opposition to
universal healthcare or expanded health coverage in the public sector
severely limits the capacity for increased equitability in health. A shift
toward universal health coverage in the United States could be a move in
the direction of reducing or eliminating a variety of health disparities both
within and outside of trans and gender-nonconforming communities that
stem from lack of access to affordable, high-quality healthcare. At the same
time, universal health coverage without trans healthcare could worsen
current health outcomes in trans and gender-nonconforming populations.
And trans health care without universal coverage will only meet the needs
of a limited set of people within these populations. Health and policy
research must investigate and propose means to ensure that these
discussions about universal access and trans health advocacy proceed in
tandem, and to ensure that trans health is understood as legitimate within a
context of a universal healthcare system.
This section has explored how current foci of trans health research on
interpersonal violence and HIV/AIDS has tended to garner more attention
than other urgent issues, such as institutional violence and health policy
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research on expansion of health coverage, to name just two examples. This
is not to imply that HIV/AIDS and interpersonal violence are not real and
important issues in trans and gender-nonconforming communities. They
are, and these topics certainly warrant attention, consideration, and the
development of strategies for reduction. However, claims that are made in
the context of health research may obscure the ways in which other
overlapping factors, such as experiences of racism, sexism, misdistribution
of wealth, and so on, may increase the likelihood of individuals in trans and
gender-nonconforming communities to encounter these issues.72 For
example, lack of access to education or employment (often in the context of
racism, classism, and sexism) might increase a trans individual’s
vulnerability to homelessness. Gender-segregated shelter systems often
refuse to house trans individuals based on gender identity or expression, and
they also frequently enforce gendered dress codes or appearance.73 In
addition, homelessness increases the likelihood that trans people will
experience interpersonal violence and institutional violence through
profiling and detention or arrest.
The focus on experiences of disease, rather than shared, parallel, or
interlocking experiences of marginalization74 within and beyond the context
of these communities, may serve to divert attention away from some of the
underlying causes of such diseases or barriers to health. Health research, in
this case, may be less productive in the form of large-scale dataset analysis
and more productive as a set of community-engaged projects to identify and
interrogate health barriers and develop initiatives that target the root causes
of these barriers. This would likely make a more tangible and beneficial
difference in the lives of trans and gender-nonconforming people than many
of the current uses of large-scale epidemiological research projects, which
are more apt to fuel policy decisions by the state that penalize transgender
people for experiencing health outcomes as a consequence of social
inequities. Alternatively, if large-scale epidemiological research projects
could significantly grow their capacity to take up questions of social
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inequities and social embeddedness, this research strategy coupled with
findings from local community-engaged research projects, could do a great
deal to influence policy more effectively.

IV. WHAT IS AT STAKE IN THE ACT OF RESEARCH INCLUSION?
To best foster and support the health of trans and gender-nonconforming
communities, it is important that we understand the health-related issues
that affect us and how we increase access and reduce barriers to healthcare.
Health research may play an important role in this. However, it is important,
before we issue an unconditional call for inclusion in research programs, to
consider the hazards of certain approaches to health research. In this
section, I will discuss some of the challenges of researching trans health in
the context of transgender as a medicalized identity. I will also discuss some
of the pitfalls of epidemiologic approaches, such as the dangers of
surveillance, the problems with reductive categories of identity, and the
ways in which health research may play a part in exacerbating
marginalization.
In Inclusion: The Politics of Difference in Medical Research, Steven
Epstein discusses the recent emergence in biomedical and pharmacological
research of the “inclusion-and-difference” model.75 He uses this term to
describe the paradigmatic shift away from “one-size-fits-all” assumptions
about population health and toward a notion of “special populations” that
require inclusion (of women, of people of color, of children, and so on) in
research and that warrant a particular scrutiny within research that takes
these “differences” into account. Epstein critiques some of the ways in
which these formations concretize and reify culturally-informed notions of
difference as fundamental, essential, and biologically based.76
This reification and “biologization” of categories is particularly troubling
because it simultaneously erases the sociopolitical context of identity and
marginalization, and it also attempts to extract categories of identity and
experience as independent and more or less separable variables.77 Janet
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Shim discusses the divergent conceptions of race held by people with
cardiovascular disease (CVD) and epidemiologists studying this disease. On
one hand, people of color with CVD described racial identities as
intertwined and inseparable from other categories of lived experience and
identity. On the other hand, epidemiologists found this inseparability to be
scientifically problematic:
The epidemiologists I interviewed . . . view the fluidity and
sensitivity of racial categories to social and political forces as
scientifically troubling—categories can appear, disappear, and
change meaning in response to the vicissitudes of the social,
cultural, and political moment. In epidemiology, demographic
variables are most conveniently managed and least subject to
measurement error or bias when they are stable and constant, and
therefore replicable and comparable over time and from study to
study.78
Given the ways in which race, class, and various other factors
contextualize the experiences and barriers to heath of trans and gendernonconforming people, it is unlikely that rich or meaningful conclusions
about health status may be reached by attempting to extract each of these
(and others) into a series of stable, independent variables. The “differenceand-inclusion” paradigm relies on these reductive notions of identity that
fail to incorporate intersectional aspects of human experience and lived
social realities.79
Further, as has been observed in non-trans gay, bisexual, and queer men’s
health advocacy, the centrality with which HIV/AIDS came to define GBQ
men’s health came at the cost of establishing broad and multi-layered
notions of health and wellbeing in these communities.80 Ideally, conducting
research in concert with developing broad intersectional social and political
projects will allow us to begin to document and establish discrepant barriers
to access, and to highlight harms facing trans and gender-nonconforming
populations.
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Some researchers, such as those in social epidemiology or other types of
research that value community engagement research, grapple with the social
context and intersectionality of identity in approaching health research.81
When discussing the process of defining “lesbian” for the sake of research,
Marj Plumb argues that “until we know who ‘we’ are, it is going to be
difficult, and rife with inaccuracy, to count us.”81 In fact, it is difficult to
imagine a way to define “transgender” in the context of health research that
would not be “rife with inaccuracy” and would not likely reinscribe
divisions of relative privilege within trans and gender-nonconforming
populations. Other modes of categorization or inquiry might capture
important themes without organizing along lines of identity—for example,
using qualitative in addition to quantitative methods, or structuring
epidemiological investigations that begin “with lay observations of health
effects.”82
A second problem with enthusiastic endorsement of inclusion in health
research is the issue of medicalization. This involves the ways in which
medicine and medical expertise, in concert with law- and policymaking,
take on the management of certain conditions, experiences, or identities.83
Epstein discusses the ways in which activists have inadvertently become
complicit in the medicalization of LGBQ and trans identities by making
arguments for the validity of LGBT health.
The likely consequence of the association of health risk with identity
categories (rather than with shared practices or shared oppression) is the
reification and medicalization of those identities. This might not be so
worrisome were it not for the long history within medicine of
conceptualizing difference as pathology.84
For trans people in particular, this may be perilous territory because the
very consolidation of trans identity as a medicalized identity may increase
perceived legitimacy and access for those of us who access or want access
to medical interventions to achieve our desired gender expression.
However, this frequently comes at the expense of our own self-
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determination and at the expense of options available to those trans
individuals (who are likely the majority) that do not want or who cannot
afford surgeries to realize a desired gender expression. Legal recognition
and support in accessing fair treatment, services, or benefits, for example, is
frequently limited to trans individuals who have identities consistent with a
medical model through surgeries or other medical intervention.85
For some trans individuals, medicalization does ground identification
with the category, but the degree to which this is true varies enormously.
Further, we have already seen the ways in which pervasive medicalization
has caused enormous damage to trans and gender-nonconforming
individuals. Many policies that govern a person’s recognition as trans for
purposes of various government agencies require medical evidence of
having had gender-affirming surgeries, even though these are not necessary
or affordable for many or most trans individuals.86 In addition, if surgeries
are desired, individuals must comply with a long and complex set of
psychiatric and medical evaluations and expectations to gain access.87 Upon
completion of these, trans individuals may access costly surgery. However,
since many insurance policies do not broadly cover such procedures at this
point, trans individuals must pay for these treatments out-of-pocket,
meaning that most people cannot access them. While the question of
medicalization differs somewhat for trans and gender-nonconforming
individuals than for LGBQ individuals, there is still a great stake in
establishing relationships with biomedical establishments that begin from a
point of self-determination rather than coercion. So long as health,
epidemiologic, and pharmacologic research takes for granted the process by
which trans and gender-nonconforming people are positioned within
biomedicine, these important sources of ill health will not enter or be
analyzed within the body of knowledge dealing with the health and
wellbeing of trans and gender-nonconforming communities.
A third caution when considering trans inclusion in research concerns the
very practice of “counting” trans and gender-nonconforming individuals

TRANSGENDER ISSUES AND THE LAW

Counting Us In

and quantifying disease burdens within this group. A variety of scholars
have argued that statistical data gathering is an instrument of population
management. As Ian Hacking argues, statistics are grounded in “the notion
that one can improve—control—a deviant subpopulation by enumeration
and classification.”88
Deborah Lupton paraphrases Michel Foucault in discussing the
emergence of “medico-administrative” knowledge. Medicine, she writes:
[B]ecame a “general technique of health” and not simply a means
of ministering to or curing the ill. Medicine was enfolded within a
system of administration, rendered part of the machinery of power,
serving as the core of the “social economy.” As part of these
changes, “population” becomes constituted as a problem, a target
for surveillance, regulation, analysis, and intervention.”89
In combination with medicine’s historical pathologization of difference,
these histories offer a cautionary message about the potential consequences
of pursuing health-based surveillance of trans communities.
Finally, the last question to consider is the ways in which, particularly
with regard to state-based health research, inclusion in research is tied to a
notion of citizenship (this has been referred to as “biomedical” or
“biopolitical” citizenship).90 The liberal, rights-based strategies that national
LGBTQ organizations have taken on in the last decade as priorities and
which center on legislative campaigns and foreground issues such as gay
marriage, hate crimes legislation, and inclusion in the military have been
critiqued for their move toward incorporation within, rather than resistance
to, state-sanctioned institutions.91 LGBTQ health advocacy has, in large
part, paralleled this, departing from the previous distrust with which federal
institutions such as the DHHS, the NIH, and the CDC were viewed, there is
now an urgent call to be considered, incorporated by and studied by these
institutions. Once again, given the ways in which state-based institutions
have been severe sources of coercion and violence for trans and gendernonconforming communities, an overreaching and uncritical desire for
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incorporation within this biomedical framework should be considered
suspect.
Some health and epidemiologic researchers have called into question
both the drive toward incorporation and the validity of the
“expert/layperson” divide. Community-based participatory research
(CBPR), an orientation toward research that values non-academic
community members as instrumental to framing research questions,
conducting research, and disseminating findings92 have been used in a
variety of health studies to establish understanding of local knowledge93
about health and wellbeing. Duran and Wallerstein discuss some of the
ways in which research with this orientation may resist pervasive
assumptions about traditional health and epidemiologic research: CBPR is
“openly emancipatory research, which challenges the colonizing practices
of positivist research and political domination by the elites.”94 Several
important studies, some of which are ongoing,95 have taken this approach to
health research. This may be a productive site for future investigations of
health disparities within these communities that transcend those constrained
by state-based agendas.
As with the AMA resolution, some kinds of health research may help to
generate more options for trans people. In continuing this work, however, it
is critical to consider the ways in which benefits will or will not be
equitably distributed across trans and gender-nonconforming communities.
Departing from the dominant health research agendas of the state might
present a set of different challenges, but it might enable us to document a
broader and more comprehensive understanding of the factors underpinning
trans and gender-nonconforming health in the United States.

V. HEALTH RESEARCH AND “LOOPING EFFECTS”
Another consideration in evaluating trans inclusion in research—albeit a
slightly more abstract one—is how people respond to the ways in which
they are categorized. Ian Hacking comments that
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[W]e tend to behave in the ways that are expected of us, especially
by authority figures—doctors, for example. . . . People classified in
a certain way tend to conform to or grow into the ways that they
are described; but they also evolve in their own ways, so that the
classifications and descriptions have to be constantly revised.96
This matters because health research plays a part in the way we, as trans
and gender-nonconforming people, see ourselves. Although this is not, as
Hacking importantly emphasizes, a one-way street, it is significant to
examine the ways in which medicine and research contextualize—and in
some ways define—our identities and experiences.
The concept of invisibility and erasure are consistent themes in the lives
of many transgender and gender-nonconforming individuals, and the case of
health is no exception. As part of the Trans PULSE community-based
research project out of Ontario, Canada, researchers found that a particular
theme that arose in qualitative research with trans community members
about perceived barriers to health was the concept of “informational and
institutional erasure.”97 This was reflected by institutions viewing trans
health as anomalous and placing the onus of system navigation on trans
individuals. Qualitative data reflected frustration with the lack of
knowledge on the part of healthcare providers about the existence and needs
of trans and gender-nonconforming individuals (informational erasure) and
a lack of policies and documents, such as medical intake forms, that listed
or acknowledged the possibility of trans and gender-nonconforming patients
accessing services (institutional erasure).98 Notably, while this research
project holds in common certain findings as some of the needs assessments,
it has uncovered a slightly different set of priorities than many health
studies that concern trans and gender-nonconforming communities. It
emphasizes administrative changes over formal legal changes, which
departs from the standard rubric of state-based LGBTQ health.99 In
addition, in its qualitative methodological approach, it attends to the range
of different needs that span trans and gender-nonconforming communities
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and captures information about the lived realities of trans and gendernonconforming individuals grappling with a concept of health and wellness
through gender non-normative positionalities.100
Interestingly, the Trans PULSE study has also captured some of the ways
in which trans people conceptualize themselves in and through research. In
discussing informational erasure, which the authors argue includes the lack
of research findings, one participant commented, “I’m one of the dead ones.
Remember [this], just because you’re [transsexual], you’re one of the dead
ones. All of this time that I’ve survived, I’m one of the walking dead
because we’re not counted; we’re not represented anywhere.”101 This is
quite a profound indication of the ways in which health research, healthcare
delivery, medicalization, professionalization, political marginalization, and
other factors have interacted to tether identity to surveillance, research, and
representation.
Ian Hacking discusses the “looping effects of human kinds.”102 He more
recently has referred to these as “interactive” kinds (contrasted with
“indifferent” kinds).103 He describes looping effects as the ways in which
“human beings and human acts come into being hand in hand with our
invention of the categories of labeling them.”104 These effects, he argues,
come “from above” (or from experts who name and categorize humans) as
well as “from below” (from those who are being named and categorized). In
a variety of ways, this “conversation” can be observed within trans and
gender-nonconforming communities to occur in the very negotiation of
naming: even in the choice to spell “transexual” with a single “s.” However,
it seems that increasingly, trans and gender-nonconforming individuals are
positioning ourselves within this conversation inside a framework of
recognition and inclusion, and research seems not to be an exception.
Further, in understanding ourselves in and through bodies of traditional
health and epidemiologic research, are we in danger of reducing our notion
of ourselves, our health, and our wellbeing to disease risk and susceptibility
to violence? Are we invoking a desire for better and nicer experts to manage
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our existences and identities, or are we calling for a broader authority and
weight of local and community-based knowledge? What is at stake in
connecting the validation of existence to health surveillance? Are there
ways that we might pursue knowledge about health and wellbeing in trans
communities that is broader, more expansive, less tied to state interests, and
more transformative in its potential for action and change? If so, how might
we position our communities, inclusive and cognizant of the marked
differences within them, to leverage our significant resilience and strength
to gather this knowledge and find solutions to the issues that compromise
and endanger our health and wellbeing?

CONCLUSION
Trans and gender-nonconforming people are clearly in need of better
quality, more comprehensive, more affordable, and more supportive
healthcare. A variety of factors, including biomedicine’s reliance on
evidence-based medicine in establishing public and private insurance
coverage policies have made research an important pursuit. But a myopic
and single-minded pursuit of health and epidemiologic research on trans
and gender-nonconforming communities fails to take into account a number
of important considerations.
First, there may be broader and more expansive ways to obtain these
necessary changes, as through the transformation of the health system to
provide universal access to healthcare inclusive of just and supportive
gender-affirming care. Second, while health research itself is not a bad idea,
a variety of features of the current frameworks of research (especially statebased research) invite thorough consideration of how trans and gendernonconforming communities want to position ourselves within these
frameworks. Third, if we continue to call for health and epidemiologic
research within our communities, it will be crucial to attend to the ways in
which relative access to privilege varies radically and to recognize that
these differences profoundly shape health disparities within our
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communities. Last, as we consider what changes in the status quo will
improve health and wellbeing for trans and gender-nonconforming
individuals, it is important to reflect on what is at stake in any of the courses
of action that we may choose to take. Health research may be a component
of this, but a departure from the course that LGBTQ health activism has
taken will probably be of great benefit in the long run. Community
engagement and local knowledge will likely strengthen and deepen the
body of knowledge that we build with regard to health, and these are more
likely to productively shape and mesh with existing community-based
movements.
Let us develop ways to pursue health research that do not leave gaps in
what we are permitted to know about ourselves. We will not gain access to
knowledge that is sufficiently rich or robust if we only enlist “experts” to
develop this knowledge and align ourselves with state agendas. An
overreliance on professionalized expertise and state-based alignment will
create a situation in which we are even less likely to attend to some of the
central factors compromising health in trans and gender-nonconforming
communities. Community-based participatory research is one way to
structure research programs in a more inclusive and productive way.
Developing and strengthening grassroots and community-based groups that
are doing work that overlaps with or within trans and gendernonconforming communities will help us continue to build on and share
local knowledge and to create alliances with overlapping communities that
may share similar barriers to health (individuals with disabilities, people of
color, low-income people, etc.).
Although it is profoundly painful and frustrating to witness the continued
marginalization of trans health within larger LGBTQ health advocacy, we
may have been granted an opportunity to take a different direction in
gathering knowledge and setting a distinct course in the pursuit of our
health and wellbeing. Let us hope that our example will inspire others to
follow.
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